🇺🇸 USA
Healthcare software and defense systems dominated parts of the ASX technology sector on Monday as Pro Medicus and Electro Optic Systems pushed deeper into large-scale international contracts.
One company expanded further into the US hospital system.
The other moved to strengthen its position in the rapidly growing counter-drone defense market.
Together, the announcements highlighted how enterprise infrastructure platforms continue separating themselves from broader tech volatility.
Pro Medicus shares rose 2.83 percent to A$125.56 after the company secured a seven-year, A$90 million agreement with US healthcare network Beth Israel Lahey Health.
Source: MarketIndex
The contract will see PME’s Visage Imaging division deploy its Visage 7 Enterprise Imaging Platform across 14 hospitals in Eastern Massachusetts and Southern New Hampshire.
The rollout includes the Visage 7 Viewer, Workflow and Open Archive systems, alongside the migration of legacy imaging archives into PME’s cloud-based infrastructure.
The healthcare network includes academic medical centres, specialty hospitals and community facilities employing more than 39,000 staff and 4,700 physicians.
Implementation planning begins immediately, with the platform expected to go live in the first quarter of calendar 2027.
The agreement continues a broader shift underway across North American healthcare systems, where hospital operators are increasingly consolidating imaging infrastructure into unified cloud-based networks capable of handling large diagnostic workloads across multiple sites.
Chief executive Dr Sam Hupert said the company’s CloudPACS strategy continued gaining traction throughout the sector.
“They join an ever-growing list of Visage 7 clients to opt for our fully cloud-based platform, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market,” Dr Hupert said.
“Our pipeline remains strong and spans all market segments. This deal is for our full stack comprising all three core Visage products, namely viewer, workflow and archive, a trend we see continuing.”
Unlike traditional software vendors operating on fixed licensing fees, PME’s model is largely transaction based.
Revenue scales alongside imaging volumes processed throughout the healthcare network.
As hospital systems grow patient throughput and diagnostic activity, PME captures increasing recurring revenue without major additional infrastructure costs.
The structure has helped PME build one of the ASX’s strongest healthcare software businesses over the past decade, particularly as hospitals continue shifting away from fragmented legacy imaging systems.
The latest deal also reinforces PME’s growing presence in the highly competitive North American imaging market, where cloud-native platforms are steadily replacing older on-premise architecture.
Elsewhere, Electro Optic Systems Holdings remained in trading halt while progressing a A$175 million capital raising linked to the acquisition of counter-drone technology business MARSS Group.
The raise includes a fully underwritten A$150 million institutional placement alongside a share purchase plan targeting up to A$25 million.
New EOS shares will be issued at A$8 each, representing a 9.3 per cent discount to the company’s last traded price.
Source: MarketIndex
The capital raising follows a major escalation in EOS’s defense pipeline after MARSS secured €102 million, or roughly A$165 million, in fresh orders tied to a Middle Eastern defense customer.
The contract expands an existing drone detection and mitigation network using MARSS’s NiDAR command-and-control platform.
Deployment is expected across 2026 and 2027, with around 70 per cent of revenue forecast during the initial rollout phase.
Military demand for autonomous surveillance and counter-drone systems has accelerated sharply following conflicts across Eastern Europe and the Middle East.
Governments are increasingly prioritising integrated sensor platforms capable of detecting, tracking and neutralising low-cost drone threats across large operational areas.
EOS’s planned acquisition of MARSS positions the company further inside that global spending cycle.
Following completion of the acquisition, EOS’s combined illustrative order book is expected to reach approximately A$726 million.
Management estimates between 60 and 80 per cent of that pipeline could convert into revenue during 2026 and 2027.
The company also expects to retain a pro-forma net cash balance near A$195 million after acquisition costs and completion of the raising.
The acquisition terms were amended alongside the latest contract expansion.
While upfront consideration remains unchanged at €36 million, the maximum earnout payable to MARSS shareholders increased from €100 million to €140 million following stronger commercial momentum and increased customer demand.
To achieve the maximum earnout cap, MARSS must generate €700 million in new order intake during the 12-month earnout period following completion.
The announcements from PME and EOS arrive as parts of the ASX technology sector continue moving in very different directions.
Consumer-facing technology names remain exposed to swings in discretionary spending and broader market sentiment.
Meanwhile, enterprise software tied directly to hospital systems, defense infrastructure and mission-critical operations continues attracting multi-year contracts with recurring revenue characteristics.
PME expanded deeper into the US healthcare system.
EOS strengthened its position inside the global counter-drone market.
Both spent Monday reinforcing how infrastructure-led software platforms are increasingly shaping the upper end of ASX technology growth.
Disclaimer - Skrill Network is designed solely for educational and informational use. The content on this website should not be considered as investment advice or a directive. Before making any investment choices, it is crucial to carry out your own research, taking into account your individual investment objectives and personal situation. If you're considering investment decisions influenced by the information on this website, you should either seek independent financial counsel from a qualified expert or independently verify and research the information.
Tags:
RECENT POSTS
TAGS
Subscribe to the Skrill Network Newsletter today and stay informed
Recommended Articles
